The four-year trial of about 70 children with "dismal prognoses" in eight hospitals across Australia will test the safety and ...

Kahimmune Therapeutics, a biotechnology company specialising in immuno-oncology, has entered an exclusive licensing agreement with Gustave Roussy and Société d’Accélération du Transfert de ...

The study, co-led by The University of Queensland and the South Australian Health and Medical Research Institute (SAHMRI), in ...

Research conducted by the University of Queensland and the South Australian Health Research Institute (SAHMRI) uses mRNA ...

Professor Brandon Wainwright of UQ's Frazer Institute is the trial's scientific lead.(Photo credit: The University of ...

SYDNEY, Feb. 3 (Xinhua) -- Australia has launched a world-first clinical trial using personalized mRNA vaccines to treat children and adolescents with advanced or treatment-resistant brain tumors.

Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price ...

A world-first trial in Australia will treat children with advanced brain cancer using technology from the COVID-19 jab.

Australia has launched the world’s first clinical trial testing personalized mRNA cancer vaccines in children suffering from ...

Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.

The emerging cancer therapy market, driven by breakthroughs like CAR-T cells and checkpoint inhibitors, offers significant growth opportunities. Companies advancing these technologies stand to benefit ...

A multicenter clinical trial published in JAMA has found that a long-used endoscopic procedure does not prevent recurrent ...